Selby_Lancet_CGH_May01_CMYK.pdf (149.57 kB)
0/0

The Lancet Gastroenterology & Hepatology Journal Cover May 1st 2017

Download (149.57 kB)
figure
posted on 06.12.2017 by Andrew Selby
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the EU, treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a more than 65% reduction in liver-related deaths, a more than 90% reduction of new viral hepatitis infections, and more than 90% of patients being diagnosed with viral hepatitis infections by 2030. This study assessed the prevalence of HCV in the EU and the level of intervention required to achieve WHO targets for HCV elimination.

Funding

Dr Robert Brierley, Dr Heather Van Epps

History

School

  • The Arts, English and Drama

Department

  • Arts

Citation

SELBY, A., 2017. The Lancet Gastroenterology & Hepatology Journal Cover May 1st 2017. The Lancet Gastroenterology & Hepatology Journal, 2(5).

Publisher

Elsevier

Version

VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Publication date

2017

Notes

This paper was accepted for publication in the journal The Lancet Gastroenterology & Hepatology Journal and the definitive published version is available at http://www.thelancet.com/journals/langas/issue/vol2no5/PIIS2468-1253(17)X0004-6.

eISSN

2468-1253

Language

en

Exports

Logo branding

Exports